Loading...
NPI 1609000439 · Quincy, IL · Nurse Practitioner
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Lisa Knuffman is a nurse practitioner provider located in Quincy, Illinois. This profile covers 38 Medicare and 4 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Lisa Knuffman |
| Address | 3301 Broadway |
| City | Quincy |
| State | IL |
| ZIP | 62301 |
| Taxonomy | Nurse Practitioner |
| NPI Enumerated | May 7, 2009 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $624.8K |
| Medicaid | $25.6K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
38 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | 8,800 | $40 | $387.2K |
| J0897 | Injection, denosumab, 1 mg | 3,540 | $20 | $67.3K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 770 | $80 | $60.7K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 220 | $80 | $17.8K |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 240 | $70 | $17.8K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 17,250 | $1 | $17.3K |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 8,460 | $1 | $16.9K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 60 | $120 | $6.6K |
| G0498 | Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community… | 30 | $170 | $5K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 40 | $130 | $4.8K |
Showing 1–10 of 38
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 38 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
38 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| J9271 | 65 | 110 | 11,600 | $40 | $564.2K |
| J0897 | 154 | 410 | 2,520 | $20 | $90.8K |
| J0881 | 42 | 70 | 11,600 | $1 | $38.2K |
| J2506 | 49 | 70 | 320 | $80 | $32.9K |
| J1439 | 58 | 80 | 25,500 | $1 | $30K |
| J9217 | 157 | 160 | 140 | $130 | $21.1K |
| J3490 | 113 | 140 | 50 | $210 | $19.4K |
| 96413 | 111 | 370 | 130 | $100 | $19.3K |
| 99214 | 674 | 18,540 | 110 | $80 | $17.1K |
| G0498 | 57 | 70 | 50 | $200 | $12K |
Showing 1–10 of 38
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
4 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,040 | $20 | $24.9K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 30 | $10 | $350 |
| 96375 | Following the administration of a drug or other substance via intravenous, or IV, push, the provider sequentially infuses a different medication or medications, also via IV push. He administers the… | 20 | $20 | $300 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 20 | $1 | $40 |
How this provider's Medicaid billing volume and revenue compare to other Illinois providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Illinois median
4 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 3,479 | 14,680 | 300 | $50 | $48.7K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 129 | 150 | 170 | $50 | $39.9K |
| 96375 | Following the administration of a drug or other substance via intravenous, or IV, push, the provider sequentially infuses a different medication or medications, also via IV push. He administers the… | 67 | 80 | 120 | $20 | $17.1K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 121 | 140 | 90 | $1 | $480 |
Other providers in the same ZIP code as Lisa Knuffman, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Board Of Trustees Of Southern Illinois University | IL | Federally Qualified Health Center (FQHC) | $0 | $9.4M |
| International Eyecare Center LLC | IL | Optometrist | $0 | $3.6M |
| Denman Services, Inc. | IL | Durable Medical Equipment & Medical Supplies | $0 | $2.9M |
| Raymond Smith | IL | Hematology & Oncology Physician | $1.5M | $54.4K |
| Robert Haag | IL | Diagnostic Radiology Physician | $946.5K | $416.5K |
| Muhammad Ali | IL | Hematology & Oncology Physician | $1.2M | $64.9K |
| Travis Moore | IL | Family Medicine Physician | $1.2M | $15.9K |
| Gerald Riley | IL | Diagnostic Radiology Physician | $816.6K | $285.5K |
| Air Evac Ems Inc. | IL | Air Ambulance | $823.9K | $37.7K |
| Ernest Wallace | IL | Family Medicine Physician | $829.9K | $23.3K |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.